ZVSAOTCPharmaceutical PreparationsFiscal year ends December 31
ZyVersa Therapeutics, Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 13, 2026
$0.05+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $388.60K
- P/E (TTM)
- –
- Dividend yield
- –
ZyVersa Therapeutics statistics
Financials through Mar 31, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | ZyVersa Therapeutics | Industry median |
|---|---|---|
| Market Cap | $388.60K | $164.85M |
| Enterprise Value | $85.94K | $87.06M |
Income (trailing twelve months)
| Measure | ZyVersa Therapeutics | Industry median |
|---|---|---|
| Operating Income | -$24.65M | -$21.44M |
| Net Income | -$24.49M | -$22.46M |
| EBITDA | -$24.65M | -$16.91M |
| EPS (Diluted) | -$3.32 | -$0.83 |
Returns
| Measure | ZyVersa Therapeutics | Industry median |
|---|---|---|
| Return on Assets (ROA) | -225.4% | -41.0% |
Balance sheet
| Measure | ZyVersa Therapeutics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $302.66K | $62.42M |
| Net Cash (Debt) | $302.66K | $15.68M |
| Net Cash Per Share | $0.04 | $0.66 |
| Equity (Book Value) | -$14.12M | $48.79M |
| Book Value Per Share | -$1.74 | $1.36 |
| Tangible Book Value | -$14.12M | $23.06M |
| Working Capital | -$14.12M | $75.77M |
Financial position
| Measure | ZyVersa Therapeutics | Industry median |
|---|---|---|
| Current Ratio | 0.05 | 3.30 |
| Quick Ratio | 0.02 | 2.39 |
Cash flow (trailing twelve months)
| Measure | ZyVersa Therapeutics | Industry median |
|---|---|---|
| Operating Cash Flow | -$4.14M | -$12.35M |
Efficiency
| Measure | ZyVersa Therapeutics | Industry median |
|---|---|---|
| Profits Per Employee | -$9 | -$703.34K |
| Employee Count | 2,800,000 | 74 |
Dividends and yields
| Measure | ZyVersa Therapeutics | Industry median |
|---|---|---|
| Earnings Yield | -6301.7% | -22.7% |
Shares
| Measure | ZyVersa Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 8,095,920 | 58,179,650 |
| Shares Change (YoY) | 316.0% | 11.1% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 7,447,120 | 49,173,100 |
| Shares Held by Insiders | 8.01% | 11.6% |
Scores
| Measure | ZyVersa Therapeutics | Industry median |
|---|---|---|
| Altman Z-Score | -395.33 | -0.24 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from ZyVersa Therapeutics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.